Try our Advanced Search for more refined results
Intellectual Property
-
February 20, 2026
Valve's Anti-Troll Law Win Could Open New Doors
The first jury verdict in the U.S. finding a patent owner violated state law meant to curb bad faith patent suits had unique circumstances that will be hard to repeat, but attorneys say Tuesday's decision still has them considering the little-used laws more closely.
-
February 20, 2026
Centripetal Wants Squires To Erase 2022 Patent Review Order
Centripetal Networks Inc. has asked U.S. Patent and Trademark Office Director John Squires to undo a 2022 decision instituting review of a cybersecurity patent that was part of its since-vacated multibillion-dollar judgment against Cisco Systems, saying the decision conflicts with his current policies.
-
February 20, 2026
7th Circ. Wary Of Tackling Jurisdiction In 2 'Schedule A' Suits
Facing requests to address alleged jurisdictional shortcomings against e-commerce platforms in two mass counterfeiting cases Friday, a Seventh Circuit panel signaled that such discussion seems unwarranted in one vendor's fee appeal while resolving the issue separately for an e-commerce intermediary might be inappropriate given its unclear case record.
-
February 20, 2026
Ex-Exec Must Arbitrate Claims In CoStar DQ-Embroiled Spat
A California federal judge sent most of a former Matterport executive's harassment and retaliation suit to arbitration, amid a suit that has prompted CoStar's efforts to disqualify Quinn Emanuel Urquhart & Sullivan LLP counsel in separate litigation.
-
February 20, 2026
BioNTech Says Moderna's New COVID Vax Infringes Its IP
BioNTech has launched a new patent infringement suit against Moderna, claiming that the rival's newer COVID-19 vaccine exploits BioNTech's "streamlined, domain-based" vaccine technology, according to a complaint filed in Delaware federal court.
-
February 20, 2026
Squires Sinks 2 PTAB Challenges, Including 1 He Instituted
U.S. Patent and Trademark Office Director John Squires has reversed his own decision and another made by the Patent Trial and Appeal Board to institute a pair of America Invents Act petitions, citing what he called the challengers' inconsistent claim construction.
-
February 20, 2026
Fed. Circ. Backs PTAB Invalidation Of VideoLabs Patent Claims
The Federal Circuit on Friday upheld a decision by the Patent Trial and Review Board that most of the challenged claims in a VideoLabs Collective patent for synchronizing data are invalid, finding VideoLabs had forfeited its argument by raising it for the first time before the circuit.
-
February 20, 2026
Fed. Circ. Unwinds Ineligibility Ruling For Gene Therapy IP
The Federal Circuit on Friday saved Regenxbio and the University of Pennsylvania's gene therapy patent, finding that splicing together genes from different organisms results in a molecule that is "markedly different from anything occurring in nature," rendering the therapy patent eligible.
-
February 20, 2026
Fed. Circ. OKs Micron's PTAB Loss In Netlist Patent Challenge
The Federal Circuit on Friday upheld Patent Trial and Appeal Board decisions that Micron Technology Inc. failed to show that claims of a Netlist Inc. computer memory patent are invalid, part of a wide-ranging dispute that includes a nine-figure verdict against Micron on other patents.
-
February 20, 2026
Dinsmore Adds IP Partner In Texas From Fish & Richardson
Dinsmore & Shohl LLP has hired a Fish & Richardson PC intellectual property lawyer who has advanced degrees in mechanical and aerospace engineering and practiced at his previous firm for more than 20 years, the firm announced Wednesday.
-
February 20, 2026
2nd Circ. Backs $286K For Childish Gambino's Attys
The Second Circuit has approved a $286,000 attorney fee award granted to lawyers representing rapper Childish Gambino and his record label in a case from another rapper who alleged part of the hit song "This Is America" was lifted from one of his tracks.
-
February 20, 2026
UK Litigation Roundup: Here's What You Missed In London
The last week in London saw the founders of Getir sue investment fund Mubadala for more than $700 million tied to alleged breaches during the company's restructuring, the Welsh Rugby Union face a claim by Swansea Council over a proposed takeover of Cardiff Rugby, and Euro Car Parks target the Competition and Markets Authority after it was fined by the watchdog. Here, Law360 looks at these and other new claims in the U.K.
-
February 19, 2026
Ex-Google Engineers Took Trade Secrets To Iran, DOJ Says
Three Silicon Valley engineers exploited their employment at Google and other major tech companies in order to steal trade secrets and send the confidential information to personal devices that they then accessed in Iran, the U.S. Department of Justice said Thursday.
-
February 19, 2026
Lab Seeks Rare Essential Patent Injunction In Wi-Fi Case
Citing recent encouragement from federal agencies, a Korean research lab is seeking a rare permanent injunction in a case involving standard essential patents, after a unit of Taiwan's Asus stipulated that its routers infringe the lab's essential Wi-Fi patents.
-
February 19, 2026
Trump's Push For Airport TMs Unprecedented, Experts Say
President Donald Trump's effort to register trademarks for airports that could someday bear his name represents a striking break from how past presidents have gotten their names placed on landmarks, intellectual property attorneys say.
-
February 19, 2026
Justices Urged To Bar Passive Infringement For Skinny Labels
The Federal Circuit cleared the path for branded-drug makers to claim a rival induced infringement of a patent without taking any active steps to do so, Hikma told the U.S. Supreme Court in a case over so-called skinny labels.
-
February 19, 2026
Producers Drop Karol G 'Gatúbela' Suit, Issue Apology
Two music producers who accused star Colombian singer Karol G and Universal Music Group of lifting the beat from their track for her hit song "Gatúbela" told a Florida federal court Wednesday that they are dropping their claims and will publicly apologize.
-
February 19, 2026
Funder Longford Wins Patent Litigation Settlement Dispute
Litigation funder Longford Capital has prevailed in arbitration relating to a dispute with Arigna Technology Ltd. over a settlement that ended certain patent litigation, according to documents filed in Delaware federal court.
-
February 19, 2026
Judge Affirms Literal Infringement In Ravgen's $57M Jury Win
A Texas federal judge has upheld a jury's finding that genetic testing company Natera Inc. committed literal infringement of a patent held by Ravgen Inc., but said Ravgen's expert testimony wasn't enough to support the jury's finding of infringement under the doctrine of equivalents.
-
February 19, 2026
Shkreli Again Tries To Add Wu-Tang Members To Album Fight
"Pharma Bro" Martin Shkreli filed a third-party complaint against two members of hip-hop group Wu-Tang Clan, seeking once again to bring them into litigation brought by a cryptocurrency community that claims Shkreli improperly retained copies of a Wu-Tang album the community had bought the rights to.
-
February 19, 2026
Flavored Air Co. Seeks Ch. 15 Nod In Nevada After Settlement
A Canadian flavored air device company is asking a Nevada bankruptcy judge to recognize the Canadian insolvency proceedings it began earlier this month after falling behind in payments from the settlement of a U.S. trademark infringement suit.
-
February 19, 2026
She Has A Point: Dechert's Kassie Helm
Kassie Helm, co-chair of Dechert LLP's global intellectual property group and head of its IP litigation group, is "unquestionably one of the leading lights of her generation," according to Morrison Foerster LLP partner Daralyn Durie, who praised Helm for her work as opposing counsel in a new series celebrating women litigators.
-
February 19, 2026
Squires Accepts 8 PTAB Cases, Walks Back 7 Merits Referrals
A bulk summary order from U.S. Patent and Trademark Office Director John Squires granted eight petitions for America Invents Act patent challenges while denying 14 others, including seven that he had previously accepted for merits-based review.
-
February 19, 2026
Fed. Circ. OKs Decision Clearing Sony In $500M Patent Case
The Federal Circuit on Thursday upheld a decision that Sony's PlayStation controllers do not infringe a computer input device patent, in a case where Sony said patent owner Genuine Enabling Technology was seeking nearly $500 million in damages.
-
February 19, 2026
Fed. Circ. Won't Revive Corcept's Drug Patent Feud
The Federal Circuit on Thursday declined to revive a case from Corcept Therapeutics Inc. in which it accused Teva Pharmaceuticals USA Inc. of patent infringement over its production of a generic version of the drug Korlym, saying a district judge didn't make a clear error in ruling Corcept hadn't shown any infringement.
Expert Analysis
-
Why Civil RICO Claims Are Gaining Traction With Plaintiffs
A Texas federal court's recent $71 million verdict in Point Bridge Capital v. Johnson demonstrates that, when used properly, civil lawsuits under the Racketeering Influenced and Corrupt Organizations Act can be a devastating weapon — and increasingly favorable for plaintiffs, says Akiva Shapiro at Gibson Dunn.
-
You're Out?: Rooftop Views Of Sports Games Raise IP Issues
A high-profile dispute between the Chicago Cubs and a rooftop business adjacent to Wrigley Field strikes at the intersection of sports, intellectual property and Chicago neighborhood tradition, highlighting novel questions that could significantly affect IP rights in the context of live events generally, say attorneys at Troutman Pepper.
-
5 Key Steps To Prepare For Oral Arguments
Whether presenting oral arguments before the U.S. Supreme Court or a local county judge, effective preparation includes the same essential ingredients, from organizing arguments in blocks to maximizing the potential of mock exercises, says Allison Rocker at Baker McKenzie.
-
A Change In Big Pharma Response To FTC Delisting Warnings
While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent listings in the U.S. Food and Drug Administration's Orange Book had been de minimis through the end of last year, July data shows an increase in delistings, say Ratib Ali and Celia Lu at Competition Dynamics.
-
9th Circ. Finding That NFTs Are Goods Will Change TM Law
The Ninth Circuit's recent ruling in Yuga Labs v. Ripps establishes that NFTs have real, commercial value under U.S. federal trademark law, a new legal precedent that may significantly influence intellectual property enforcement and marketplace policies regarding digital assets going forward, say attorneys at Wilson Elser.
-
Series
Adapting To Private Practice: From Texas AUSA To BigLaw
As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.
-
Data Undermines USPTO's 'Settled Expectations' Doctrine
An analysis of inter partes review proceedings filed since 2012 appears to refute the U.S. Patent and Trademark Office's recent stance that patent owners develop a strong settled expectation that their patents will not be challenged after being in force for six years, say Jonathan DeFosse and Samuel Smith at Sheppard Mullin, and Kenzo Kasai at NGB Corp.
-
Advice For 1st-Gen Lawyers Entering The Legal Profession
Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.
-
Fed. Circ. In July: Instability In IPR Requirements
The Federal Circuit's decision in Shockwave v. Cardiovascular last month provided an important, albeit short-lived, clarification to the type of evidence that can be used in an inter partes review challenge, say attorneys at Knobbe Martens.
-
Structuring Noncompetes In License And Collaboration Deals
As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.
-
Series
Coaching Cheerleading Makes Me A Better Lawyer
At first glance, cheerleading and litigation may seem like worlds apart, but both require precision, adaptability, leadership and the ability to stay composed under pressure — all of which have sharpened how I approach my work in the emotionally complex world of mass torts and personal injury, says Rashanda Bruce at Robins Kaplan.
-
7 Ways To Fetch Patents In The World Of Working Animals
Though developers rarely file patents related to working animals, and animal training techniques are generally considered unpatentable, certain aspects of training and developing animals may be ripe for patent protection, say Matthew Avery at Baker Botts, Makenzi Galvan at Perkins Coie and Lute Yang at Orrick.
-
Ruling Puts 11th Circ. At Odds With Bankruptcy Courts
While an Eleventh Circuit majority recently found in BenShot v. 2 Monkey Trading and Lucky Shot USA that corporate debtors, like individuals, face certain exceptions to discharge under a nonconsensual Subchapter V plan, the ruling not only reverses the lower court, but opposes the holdings of many other bankruptcy courts, say attorneys at McDermott.
-
Series
Law School's Missed Lessons: How To Make A Deal
Preparing lawyers for the nuances of a transactional practice is not a strong suit for most law schools, but, in practice, there are six principles that can help young M&A lawyers become seasoned, trusted deal advisers, says Chuck Morton at Venable.
-
A New IP Game Plan For College Football Players
For college stars navigating their first season under the newly implemented settlement in House v. NCAA and new NFL recruits, securing trademark rights isn't just a savvy business move — it's essential for building and protecting a personal brand that can outlast their playing days, says Ryan Loveless at CM Law.